Solid IO
Helsinki, Finland
Solid IO is a healthcare startup focused on transforming cancer care through advanced organ-on-chip technology. Their tumor-on-chip platform replicates the tumor microenvironment, providing real-time, patient-specific insights that enable oncologists to make informed treatment decisions. By bridging the gap between research and clinical applications, Solid IO aims to enhance precision in oncology, reduce the trial-and-error nature of current treatments, and integrate early-stage drug development with predictive analytics. The company’s technology supports researchers, clinicians, and pharmaceutical entities in optimizing treatment strategies and accelerating the advancement of immunotherapy and tailored therapies for cancer patients.
Company Info
- Founded
- 2025
- Website
- www.solid-io.com/
Only accessible to MedStartr community members.
Join nowWhat do you think of Solid IO?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Comments
Comments from new members are shown once the company's team has approved them. Please follow the community rules.
Sign in to join the conversation.
Sign in to comment